Inozyme Pharma Inc. (INZY) NASDAQ

$5.08 0.02 (0.40%)

Market Cap: $202.89M

As of 06/24/22 04:00 PM EDT. Market closed.

(INZY)

Inozyme Pharma Inc. (INZY) NASDAQ

$5.08 0.02 (0.40%)

Market Cap: $202.89M

As of 06/24/22 04:00 PM EDT. Market closed.

Inozyme Pharma is a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization. Through the company's in-depth understanding of the biological pathways involved in mineralization, company is pursuing the development of therapeutics to address the underlying causes of these debilitating diseases. It is well established that two ... read more

Inozyme Pharma is a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization. Through the company's in-depth understanding of the biological pathways involved in mineralization, company is pursuing the development of therapeutics to address the underlying causes of these debilitating diseases. It is well established that two genes, ENPP1 and ABCC6, play key roles in a critical mineralization pathway and that defects in these genes lead to abnormal mineralization. Inozyme is initially focused on developing a novel therapy to treat the rare genetic diseases of ENPP1 and ABCC6 deficiencies. read less

COMPANY PROFILE
Sector
Industry
URL
Address
.
Sector
Industry
Full Time Employees
38
Address
.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$5.07
Previous Close
$5.06
Days Range
$4.43 - $5.33
52 week range
$3.15 - $19.58
Volume
1,827,855
Avg. Volume (30 days)
253,071
Market Cap
$202.89M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
40,097,076
Open
$5.07
Previous Close
$5.06
Days Range
$4.43 - $5.33
52 week range
$3.15 - $19.58
Volume
1,827,855
Avg. Volume (30 days)
253,071
Market Cap
$202.89M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
40,097,076

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR INOZYME PHARMA INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Longitude Capital Partners III, LLC 10% Owner Apr 19, 2022 Buy $3.69 1,355,000 4,999,950 4,174,379 Apr 21, 2022, 06:04 PM
Pivotal bioVenture Partners Fund I, L.P. Director Apr 19, 2022 Buy $3.69 1,070,000 3,948,300 2,661,154 Apr 20, 2022, 06:22 PM
Bjarke Henric Bjorn SVP, COO Apr 19, 2022 Buy $3.69 27,100 99,999 80,626 Apr 20, 2022, 04:05 PM
Bolte Axel Chief Executive Officer Apr 19, 2022 Buy $3.69 67,750 249,998 258,575 Apr 20, 2022, 04:05 PM
Hopfner Robert Lorne Director Apr 19, 2022 Buy $3.69 1,070,000 3,948,300 2,661,154 Apr 20, 2022, 04:05 PM
Subramanian Sanjay SVP, CFO Apr 19, 2022 Buy $3.69 27,100 99,999 27,100 Apr 20, 2022, 04:05 PM
Bolte Axel Chief Executive Officer Jun 24, 2021 Option Exercise $0.98 66,788 65,452 257,613 Jun 25, 2021, 07:58 AM
Bolte Axel Chief Executive Officer Jun 24, 2021 Sale $0.00 66,788 7 190,825 Jun 25, 2021, 07:58 AM
Novo Holdings A/S 10% Owner Jan 28, 2021 Sale $21.00 375,000 7,875,000 2,194,379 Feb 01, 2021, 04:30 PM
Novo Holdings A/S 10% Owner Jul 28, 2020 Buy $16.00 375,000 6,000,000 2,569,379 Jul 29, 2020, 05:29 PM
Sanofi 10% Owner Jul 28, 2020 Buy $16.00 81,250 1,300,000 520,125 Jul 29, 2020, 06:06 AM
Rock Springs Capital Management LP 10% Owner Jul 28, 2020 Buy $16.00 600,000 9,600,000 1,067,884 Jul 28, 2020, 08:53 PM
RA CAPITAL MANAGEMENT, L.P. 10% Owner Jul 28, 2020 Buy $16.00 600,000 9,600,000 2,003,653 Jul 28, 2020, 06:33 PM
Sonsini Peter W. 10% Owner Jul 28, 2020 Buy $16.00 250,000 4,000,000 2,437,689 Jul 28, 2020, 06:30 PM
SANDELL SCOTT D 10% Owner Jul 28, 2020 Buy $16.00 250,000 4,000,000 2,437,689 Jul 28, 2020, 06:29 PM
MAKOWER JOSHUA 10% Owner Jul 28, 2020 Buy $16.00 250,000 4,000,000 2,437,689 Jul 28, 2020, 06:29 PM
Makhzoumi Mohamad 10% Owner Jul 28, 2020 Buy $16.00 250,000 4,000,000 2,437,689 Jul 28, 2020, 06:28 PM
Florence Anthony A. Jr. 10% Owner Jul 28, 2020 Buy $16.00 250,000 4,000,000 2,437,689 Jul 28, 2020, 06:27 PM
BASKETT FOREST 10% Owner Jul 28, 2020 Buy $16.00 250,000 4,000,000 2,437,689 Jul 28, 2020, 06:26 PM
New Enterprise Associates 15, L.P. 10% Owner Jul 28, 2020 Buy $16.00 250,000 4,000,000 2,437,689 Jul 28, 2020, 06:26 PM
Longitude Capital Partners III, LLC 10% Owner Jul 28, 2020 Buy $16.00 625,000 10,000,000 2,819,379 Jul 28, 2020, 06:20 PM
Pivotal bioVenture Partners Fund I, L.P. 10% Owner Jul 28, 2020 Buy $16.00 187,500 3,000,000 1,591,154 Jul 28, 2020, 06:15 PM
Hopfner Robert Lorne Director Jul 28, 2020 Buy $16.00 187,500 3,000,000 1,591,154 Jul 28, 2020, 06:11 PM
Sofinnova Venture Partners X, L.P. 10% Owner Jul 28, 2020 Buy $16.00 437,500 7,000,000 2,028,308 Jul 28, 2020, 06:08 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Longitude Capital Partners III, LLC 10% Owner 04/19/2022 4,999,950
Pivotal bioVenture Partners Fund I, L.P. Director 04/19/2022 3,948,300
Bjarke Henric Bjorn SVP, COO 04/19/2022 99,999
Bolte Axel Chief Executive Officer 04/19/2022 249,998
Hopfner Robert Lorne Director 04/19/2022 3,948,300
Subramanian Sanjay SVP, CFO 04/19/2022 99,999
Bolte Axel Chief Executive Officer 06/24/2021 65,452
Bolte Axel Chief Executive Officer 06/24/2021 7
Novo Holdings A/S 10% Owner 01/28/2021 7,875,000
Novo Holdings A/S 10% Owner 07/28/2020 6,000,000
Sanofi 10% Owner 07/28/2020 1,300,000
Rock Springs Capital Management LP 10% Owner 07/28/2020 9,600,000
RA CAPITAL MANAGEMENT, L.P. 10% Owner 07/28/2020 9,600,000
Sonsini Peter W. 10% Owner 07/28/2020 4,000,000
SANDELL SCOTT D 10% Owner 07/28/2020 4,000,000
MAKOWER JOSHUA 10% Owner 07/28/2020 4,000,000
Makhzoumi Mohamad 10% Owner 07/28/2020 4,000,000
Florence Anthony A. Jr. 10% Owner 07/28/2020 4,000,000
BASKETT FOREST 10% Owner 07/28/2020 4,000,000
New Enterprise Associates 15, L.P. 10% Owner 07/28/2020 4,000,000
Longitude Capital Partners III, LLC 10% Owner 07/28/2020 10,000,000
Pivotal bioVenture Partners Fund I, L.P. 10% Owner 07/28/2020 3,000,000
Hopfner Robert Lorne Director 07/28/2020 3,000,000
Sofinnova Venture Partners X, L.P. 10% Owner 07/28/2020 7,000,000
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2022
09/30/2021
0.70%
2Q
03/31/2022
06/30/2021
0.96%
3Q
03/31/2022
03/31/2021
1.10%
4Q

Period of Report: 03/31/2022

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2021
0.70%
2Q
06/30/2021
0.96%
3Q
03/31/2021
1.10%
4Q